C Szostecki
Overview
Explore the profile of C Szostecki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
600
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Guldner H, Szostecki C, Schroder P, Matschl U, Jensen K, Luders C, et al.
J Cell Sci
. 1999 Feb;
112 ( Pt 5):733-47.
PMID: 9973607
Sp100 and PML are interferon-inducible proteins associated with a new class of nuclear domains (known as nuclear dots or PML bodies) which play a role in tumorigenesis, virus infections, and...
2.
Zuchner D, Sternsdorf T, Szostecki C, Heathcote E, Will H
Hepatology
. 1997 Nov;
26(5):1123-30.
PMID: 9362351
Antinuclear antibodies (ANA) staining nuclear dot structures predominantly occur in primary biliary cirrhosis (PBC) patients and recognize the Sp100 and promyelocytic leukemia protein (PML). From retrospective analysis of sera from...
3.
Szostecki C, Guldner H, Will H
Semin Liver Dis
. 1997 Feb;
17(1):71-8.
PMID: 9089912
Autoantibodies against nuclear proteins are not always but rather frequently present in sera of patients with primary biliary cirrhosis (PBC). The specificity and diagnostic value of these autoantibodies for PBC...
4.
Grotzinger T, Jensen K, Guldner H, Sternsdorf T, Szostecki C, Schwab M, et al.
Mol Cell Biol
. 1996 Mar;
16(3):1150-6.
PMID: 8622659
In human cells, three proteins are currently known to colocalize in di screte nuclear domains (designated nuclear dots): Sp100, a transcription-activating protein autoantigenic primarily in patients with primary biliary cirrhosis;...
5.
Sternsdorf T, Guldner H, Szostecki C, Grotzinger T, Will H
Scand J Immunol
. 1995 Aug;
42(2):257-68.
PMID: 7631159
The nucleoproteins Sp100 and PML, the first an autoantigen predominant in patients with primary biliary cirrhosis (PBC) and the second a transformation and cell growth suppressing protein aberrantly expressed in...
6.
Szostecki C, Will H, Guldner H
Z Arztl Fortbild (Jena)
. 1994 Aug;
88(7-8):573-8.
PMID: 7856263
No abstract available.
7.
Koken M, Guillemin M, Viron A, Stuurman N, de Jong L, Szostecki C, et al.
EMBO J
. 1994 Mar;
13(5):1073-83.
PMID: 8131741
Nuclear bodies (NBs) are ultrastructurally defined granules predominantly found in dividing cells. Here we show that PML, a protein involved in the t(15;17) translocation of acute promyelocytic leukaemia (APL), is...
8.
Guldner H, Szostecki C, Grotzinger T, Will H
J Immunol
. 1992 Dec;
149(12):4067-73.
PMID: 1281200
About 30% of patients suffering from the chronic autoimmune liver disease primary biliary cirrhosis produce autoantibodies against Sp100, a protein migrating in SDS-PAGE at a position corresponding to 100 kDa...
9.
Szostecki C, Will H, Netter H, Guldner H
Scand J Immunol
. 1992 Oct;
36(4):555-64.
PMID: 1384113
Sp100, a protein with a dot-like intranuclear localization in immunofluorescence microscopy, is a major target for patient autoantibodies in primary biliary cirrhosis (PBC) and occasionally in rheumatic disorders. The human...
10.
Netter H, Will H, Szostecki C, Guldner H
J Autoimmun
. 1991 Aug;
4(4):651-63.
PMID: 1723274
The major target of anti-(U1)snRNP autoantibodies, a serological marker of patients with mixed connective tissue disease and related rheumatic disorders, is a 68 kDa protein (p68) associated with (U1)RNA-containing small...